About Superluminal Medicines:
Superluminal Medicines (Superluminal) is a generative biology and chemistry company revolutionizing the speed and accuracy of how small molecule medicines are created. The Company’s platform aims to create candidate-ready compounds with unprecedented speed using a combination of deep biology, computational and medicinal chemistry, machine learning, and proprietary big data infrastructure. We are expanding the team of talented scientists who seek to build the future of small molecule drug discovery with creativity and innovation.
About the Role:
Superluminal Medicines, Inc. is seeking a highly motivated and collaborative Research Associate with experience in GPCR pharmacology and drug discovery to join our growing and dynamic Biology team. We are a target and biology-first drug discovery organization leveraging artificial intelligence and machine learning (AI/ML) to address common bottlenecks in drug development while integrating biology, chemistry, and computation.
This is a unique opportunity to contribute meaningfully to impactful drug discovery efforts, grow your expertise in cutting-edge biology and drug discovery, and help address unmet healthcare needs worldwide.
Roles and Responsibilities:
- Develop and perform in vitro assays to support drug discovery programs with precision and attention to quality to generate high quality data.
- Troubleshoot and analyze experimental data with a high degree of scientific integrity.
- Ensure proper operation and maintenance of laboratory instruments and equipment.
- Accurately document experimental data in laboratory notebooks and computer files, adhering to established quality and regulatory guidelines.
- Communicate experimental results effectively in written and oral formats to interdisciplinary teams, including computational biologists and machine learning scientists.
- Follow standard operating procedures (SOPs) and develop new experimental methods based on existing literature.
- Present findings at team meetings.
Requirements:
- BS/MS in Pharmacology, Biochemistry, Biology, or related field, with 2–5 years of relevant laboratory experience in GPCR pharmacology or drug discovery.
- Strong hands-on experience in biochemical, cellular, and/or binding assays with the ability to ensure high-quality assay data.
- Familiarity with GPCR biology, Pharmacology is essential.
- Excellent laboratory skills, including cell culture, preparation of reagents, and the use of laboratory instrumentation and related software.
- Ability to work independently to follow experimental designs and troubleshoot experiments.
- Strong organizational skills, attention to detail, and a proactive work ethic.
- Effective communication skills and the ability to collaborate in a multidisciplinary team environment.
- Small molecule experience is a bonus but not required.
This is a lab-based position that requires a hands-on, innovative approach to advancing discovery efforts.
Key Attributes for Success:
- Ability to adapt to a fast-paced, dynamic environment and effectively manage shifting priorities.
- Creative and innovative mindset to contribute to cutting-edge approaches in small molecule discovery.
- Strong coordination skills to collaborate with internal teams and external stakeholders.
Equal Opportunity Statement:
Superluminal Medicines is an Equal Opportunity Employer committed to a culturally diverse workforce. All qualified applicants will receive consideration for employment without regard to race; color; creed; religion; national origin; age; ancestry; nationality; marital, domestic partnership or civil union status; sex, gender, gender identity or expression; affectional or sexual orientation; disability; veteran or military status or liability for military status.
Top Skills
What We Do
Superluminal Medicines is a Boston-based generative biology and chemistry company developing a differentiated pipeline and revolutionizing the speed and accuracy of how medicine is created.
Our platform creates candidate-ready compounds with unprecedented speed using a comprehensive combination of deep biology and chemistry expertise, machine learning, and proprietary big data infrastructure.
The predict-design-test architecture accurately models protein shapes and designs highly selective compounds to target the precise structural change for therapeutic effect. Our discovery engine is powered by an industry-leading, pharmacokinetic and toxicology in silico prediction capability.
With a lead program candidate expected in the near term, our proprietary pipeline validates our platform with initial programs focused on high-value GPCR targets. We’re pleased to be backed by a strong network of investors including RA Capital Management, Insight Partners, NVentures, Catalio Capital Management, Eli Lilly and Company, Gaingels, and Cooley LLP.
